Evidence map›Paper›PMID 40070621›Full record

ArticleCureus2025

Clearing the Path: Redefining Hepatolithiasis Removal Through Endoscopic Hepaticogastrostomy.

Woo Suk Kim, Tasur Seen, Krishna Gurram

Abstract readCase Reports
In one paragraph

Article in Cureus, 2025. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Not yet cited in PubMed.

0numbers the graph read from it
0cells of the map it votes in
0citing papers in PubMed
–field-weighted citation impact
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

0 citing papers in PubMed.

No citing paper in PubMed yet.

4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

3 authors.

Woo Suk KimInternal Medicine, Icahn School of Medicine at Mount Sinai, Queens, USA.
Tasur SeenGastroenterology, Icahn School of Medicine at Mount Sinai, Queens, USA.
Krishna GurramGastroenterology, Icahn School of Medicine at Mount Sinai, Queens, USA.

Funding

No grant is acknowledged in the PubMed record.

6 · The paper itself

Abstract

Hepatolithiasis is a condition characterized by the presence of bile stones in the intrahepatic bile ducts. It represents a significant therapeutic challenge owing to its association with recurrent cholangitis, biliary obstruction, and potentially life-threatening complications such as hepatic abscesses and cholangiocarcinoma. Traditional treatments include hepatectomy and percutaneous transhepatic cholangioscopic lithotomy (PTCL), both of which are effective but highly invasive, whereas endoscopic approaches often leave residual stones. We report a case of recurrent hepatolithiasis with abscesses in an 80-year-old woman who had failed to respond to conventional endoscopic approaches. Endoscopic ultrasound (EUS)-guided hepaticogastrostomy was successfully performed through the transgastric approach to allow access to intrahepatic stones for clearance with complete symptomatic relief and no further evidence of recurrence during follow-up. This case demonstrates the use of hepaticogastrostomy as a less invasive alternative to surgery while serving both diagnostic and therapeutic purposes. Further studies are needed to delineate its role as well as its long-term efficacy in the management of hepatolithiasis.

Indexed as

endoscopic retrograde cholangiopancreatography (ercp)endoscopy interventionhepaticogastrostomyhepato-biliaryhepatolithiasis

Identifiers

PMID40070621
PMCPMC11896014

What OpenQuestion holds

Textmetadata
LicenceCC BY
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.